研究課題/領域番号 |
20K18934
|
研究種目 |
若手研究
|
配分区分 | 基金 |
審査区分 |
小区分58030:衛生学および公衆衛生学分野関連:実験系を含まない
|
研究機関 | 一橋大学 |
研究代表者 |
Rouyard Thomas 一橋大学, 社会科学高等研究院, 特任講師 (40859542)
|
研究期間 (年度) |
2020-04-01 – 2024-03-31
|
研究課題ステータス |
交付 (2022年度)
|
配分額 *注記 |
4,030千円 (直接経費: 3,100千円、間接経費: 930千円)
2021年度: 1,430千円 (直接経費: 1,100千円、間接経費: 330千円)
2020年度: 2,600千円 (直接経費: 2,000千円、間接経費: 600千円)
|
キーワード | type 2 diabetes / self-management / behavioural intervention / risk communication / heart age / primary care / cluster randomised trial / nudge / shared decision-making |
研究開始時の研究の概要 |
This study will explore the effects of using an innovative risk communication tool developed to help physicians better communicate diabetes-related risks during routine consultation. The impact on patients' risk perceptions, doctor-patient communication, and risk management will be assessed.
|
研究実績の概要 |
- The study aims to evaluate the effects of a personalized behavioral intervention (‘FEEDBACK’) developed to improve self-management behavior in adults with type 2 diabetes. FEEDBACK is a resource-minimizing intervention designed to be delivered by general practitioners (GPs) in routine primary care settings. The study is a cluster randomized controlled trial (RCT) with six months follow-up. - In Japan, where the implementation of primary care policy has just begun, it is necessary to introduce evidence-based, person-centered diabetic care into the practice of GPs nationwide. If we could link our FEEDBACK intervention with improved patient outcomes and delivery in primary care, this would provide further justification for stronger primary care services and investment in primary care in Japan.
2022: - After numerous study implementation challenges and delays encountered in 2020 and 2021 due to the COVID-19 pandemic, we have now managed to make good progress in the recruitment process. Eighteen GP practices have been recruited so far, which is close to our initial sample size objective (n=20). We would like to recruit a few more practices to ensure that our pre-registered minimum effect size of interest can be detectable. - As we made good process on the recruitment process, we submitted the study protocol for publication in an international peer-reviewed journal in January 2023. The manuscript has been accepted for publication in the journal 'Trials'.
|
現在までの達成度 (区分) |
現在までの達成度 (区分)
4: 遅れている
理由
For a large part, the project's delay has been due to the restrictions and additional burden imposed on GPs by the COVID-19 pandemic. However, as indicated in last year's report, we have also come to realize that Japanese GPs are generally not used to engage in clinical intervention research and may feel a little overwhelmed by it, which has made the recruitment process even more challenging. Despite these challenges, our efforts have eventually paid off and we are confident that we will complete recruitment by September 2023.
|
今後の研究の推進方策 |
- Once recruitment is completed, we will start the intervention period. We are confident that this will be implemented in the second half of 2023. - We expect the study to be brought to the attention of a large international audience of clinicians and health policymakers. Findings of the study will be disseminated to the largest possible audience through presentations at international conferences and publication in international peer-reviewed journals.
|